Calla Lily Clinical Care

Grateful to BBC News for spotlighting our work on progesterone-#Callavid, our novel drug delivery technology aimed at helping treat threatened miscarriage. "The current delivery method can leak and cost the [British economy and] NHS up to £236m per year, health economists say. University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is leading the trial and said more than 150,000 women in the UK could be eligible for prescriptions of progesterone." We're proud to be working on a solution with the potential for meaningful impact in #womenshealth Article here: https://lnkd.in/eYXbbnv2 #womenshealth #healthcareinnovation #femtech #bthechange #miscarriagesupport #ivfsupport #NIHRfunded #callavid #drugdelivery

Honoured to be speaking at the 34th Singapore Pharmacy Congress 🇸🇬 to share the development journey and translational strategy behind our #Callavid vaginal drug delivery platform. Calla Lily Clinical Care is focused on advancing a #patientcentric solution that delivers targeted and user-friendly therapies for conditions with high unmet clinical need. I’ll be sharing our initial use cases, including support for IVF and prevention of threatened miscarriage, along with the broader pipeline potential - spanning hormonal therapies, biotherapeutics, and anti-infectives. Grateful to Professor Matthias G. Wacker of National University of Singapore and the #SPC25 steering committee for the opportunity to join esteemed fellow panellists (Sui Yung Chan, Ayca Altay Benetti, PhD, Charles Stacey) working at the forefront of pharmaceutical innovation and #womenshealth. Royal Pharmaceutical Society #healthcareinnovation #femtech #bthechange #menopause #miscarriagesupport #ivfsupport #endometriosis #bvtreatment #callavid #drugdelivery

Last week was a busy one with LSI Europe and an invitation to join the University of North Carolina at Chapel Hill Global Well event in London. I had the true honor having lunch with Vice Chancellor Michael Andreasen the day before. We had a really good giggle and plotted ways to bring #Callavid and our work at Calla Lily Clinical Care to Chapel Hill. Or maybe an Unstable Vitals episode filmed on campus with my fellow UNC Kenan-Flagler Business School alum, Adam Brown, MD MBA. The following evening we were treated to dinner and a fireside chat with Chancellor Lee Roberts who shared his vision for how UNC can continue to grow and thrive in this uncertain world. There is something very special about being a Tar Heel! #founderlife

To set the stage for our inaugural event in Boston, we'll be co-hosting a webinar with FutureFemHealth on Sept. 29. As we head into the later half of 2025, the discussion will focus on key trends and pain points in women's health innovation. Panelists include: Lara Zibners MD MMEd MBA, Co-Founder, Calla Lily Clinical Care Sophia Yen, MD, MPH, Co-Founder, CEO Pandia Health Laura Minquini, Founder of AthenaDAO Anna O'Sullivan, Founder of FutureFemHealth Moderated by Ashleigh Niziol of Women’s Health Horizons (WHH), expect a 45 minute live chat with special guests, with plenty of time for questions. Topics we'll cover: 🟢 Alternative investments streams in women's health 🟢 Why women's health is not just fertility and how we need to outside of bikini medicine 🟢 The nuanced rise of menopause and longevity 🟢 Responsible use of women's health data 🟢 Censorship in women’s health as an ongoing systemic barrier for many startups and innovators + more 👉 Register today: https://luma.com/i0a9c40k 🗓️ Sept. 29, 2025 - 5pm BST/9am PDT/12pm EST #WomensHealth #HealthInnovation #WHH #FutureOfHealth #HealthEquity #FemTech #WomenInHealth #Womenshealthhorizons #Boston

We’re delighted to welcome Lisa Huddlestone, PhD to the team as a Research Analyst and Zinc NIHR Innovation Fellow! Lisa holds a PhD in Epidemiology and Public Health from the University of Nottingham and brings over a decade of experience in developing and evaluating technologies to improve both physical and mental health outcomes. Her expertise in participatory and user-centred research, systematic evidence synthesis, and translating findings into actionable solutions will be invaluable as we continue our journey to bring the Callavid® drug delivery platform from bench to bedside. Welcome, Lisa great to have you on board! 🚀 Thank you to Zinc, NIHR (National Institute for Health and Care Research) & Vivensa Foundation for having us be part of this year’s cohort. #teamwork #womenshealth #miscarriagesupport #growthmindset #fertility #bcorp #bthechange #ivfsupport #endometriosis #bvtreatment #callavid #tampliner #lilyvid

It’s been a superb 2 days in Munich at the office overlooking the alps of Essity - one of the world’s leading health and hygiene companies 🇸🇪.  Beyond the stunning views, it was very powerful and poignant to get a deep dive into how a $15B+ revenue company truly thinks about and integrates #innovation. Some thoughts: 💥 Breaking Taboos with Courage💥 It was deeply meaningful to meet the people behind one of the most groundbreaking campaigns I’ve ever seen: Essity’s #BloodNormal.  Back when we were solely focused on the consumer Tampliner® application of our technology, that campaign set the gold standard: bold, unapologetic, and necessary. Even now, the original ad still gives me inspired chills (link in comments).  Such a powerful reminder of how impactful it is when companies choose to lead with #courage. 💥 Not Just Talking the Talk on #womenshealth 💥 It was genuinely inspiring to see Essity move beyond lip service when it comes to women’s health and menopause. Their efforts go far beyond traditional late-stage M&A- including strategic collaborations with startups, and to Essity’s commitment and investment with Issviva, their creation of an independent in-house menopause startup.  💥 Learning from the Professionals 💥 Spending time with Essity experts and senior leaders was so insightful. There were too many takeaways to list, but all the learnings lead to one big reminder: startups don’t own the monopoly on speed, disruption, or collaborative culture. These two days showed how much we can learn from each other, and how innovation thrives in unexpected places. Thanks to Volker Zöller, Kai Thornagel, Gael De Talhouet, Tilda Selemark, Stacey van Hooven, Joanna Campillo, Duncan Phillips, Zhanna Gorovaya, Linda Andén-Pantera for such a thoughtful and energising experience. #bthechange #womenshealth #medtech #tampliner Callaly #callavid

The financing environment remains difficult for solutions addressing women’s health, Lara Zibners MD MMEd MBA, co-founder and chair of Calla Lily Clinical Care., told BioWorld. “Until I entered this space, I've never spoken to an investor in any other area who said ‘I need to go home and ask my wife’,” she said on the sidelines of the LSI conference in London. Read Shani Alexander’s article in BioWorld News https://lnkd.in/dwCvYETN

🙏 Pregnancy loss affects up to 25% of all pregnancies, yet it remains one of the most overlooked areas of women's health innovation. Despite affecting millions globally, the field has been characterized by long wait times, limited treatment options, and persistent stigmatization. Now, a new generation of entrepreneurs is developing solutions across the pregnancy loss journey. Companies like Fertia Health GmbH are providing integrated digital platforms combining medical expertise with psychological support, while Sibyl offers AI-powered emotional support with 24/7 guidance. Calla Lily Clinical Care is developing a device addressing progesterone leakage during threatened miscarriage treatment. 💬 "There's a fundamental misunderstanding that recurrent pregnancy loss is solely a fertility issue. Investment in improved pregnancy loss care would generate significant long-term benefits for individuals and society alike." Prof. Dr. Ruben Kuon, University of Heidelberg & Fertia Health GmbH 👉 Full story: https://lnkd.in/gpu459jf #femtech #womenshealth #pregnancyloss #reproductivehealth #maternalhealth #healthcareinnovation #digitalhealth #healthtech #miscarriage #fertility #mentalhealth #startups #funding #innovation

Super excited about this new event 💥 Join us on October 8th for a panel on the future of pregnancy loss care—what’s missing, what’s changing, and what’s next. Hosted by WHIC - Womens Health Innovation Council - a panel of incredible experts consisting of 🌟Melissa Ablett-Jordaan, founder of Sibyl 🌟Lara Zibners MD MMEd MBA, co-founder of Calla Lily Clinical Care 🌟Frank Khan Sullivan, cofounder Enhanced Fertility 🌟Liona CY Poon 潘昭頤 , founder PregnaSense brings together clinical, emotional, and tech perspectives on one of the most overlooked areas in women’s health. Details and registration: https://lnkd.in/ecWx6_YJ #ReproductiveHealth #PregnancyLoss #HealthInnovation Sophie van Dijk Maaike Steinebach